ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Ubrogepant Reduced Migraine-Related Limitations When Taken During the Prodrome Phase"
Episode Synopsis
According to a study published in Neurology, when compared to placebo, this gepant led to significantly greater ability to function normally and a greater reduction in activity limitation when taken during the prodrome phase of an attack. Molly O'Brien has the details in this Migraine Minute News Update. : https://bit.ly/3BY2J9d
More episodes of the podcast Migraine Minute News Update
Diabetes Drug May Cut Migraine Days in Half
19/09/2025
How Might Stress Trigger Migraine Pain?
01/08/2025
Does PACAP 38 Work Differently Than CGRP?
06/06/2025
In God we trust